Lisha Yu

KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma

Shilong Yan, Jingnan Zhang, Jing Guan, 2022, Disease markers.

Pemetrexed for Recurrent Primary Central Nervous System Lymphoma in the Elderly: Results of a Retrospective Study

J. Xiao, Bing Xu, Lisha Yu, 2022, Journal of healthcare engineering.

Design, synthesis, and biological evaluation of novel molecules as potent inhibitors of PLK1.

X. Wang, L. Wang, G. Du, 2023, Bioorganic chemistry.